Literature DB >> 33668493

Obesity, Nutrients and the Immune System in the Era of COVID-19.

Jean-Pascal De Bandt1, Charlotte Monin1.   

Abstract

The past year has shown that obesity is a risk factor for severe complications of SARS-CoV-2 infection. Excess fat mass during obesity is known to be a risk factor for chronic diseases but also for severe infections and infectious complications. We have focused here on the elements responsible for this particular susceptibility to infections and more specifically to COVID-19. Excess fat is, in itself, responsible for alterations of the immune system by disrupting the production and function of immune cells. Indeed, hypertrophic adipocytes produce more pro-inflammatory adipokines (including cytokines). The increase in their apoptosis induces a release of pro-inflammatory compounds into the circulation and a recruitment of pro-inflammatory macrophages into the adipose tissue. A chronic systemic inflammatory state is then observed. In addition, diet, apart from its role in the development of adipose tissue, can also affect the immune system, with excess simple sugars and saturated fats exerting pro-inflammatory effects. This inflammation, the adipokines released by the adipocytes, and the infiltration of lipids into the lymphoid organs affects the production of immune cells and, directly, the functions of these cells. The alteration of the immune system increases the risk of infection as well as complications, including secondary bacterial infections and septic states, and increases infection-related mortality. During COVID-19, the chronic inflammatory state promotes the cytokine shock, characteristic of severe forms, caused in particular by excessive activation of the NLRP3 inflammasome. Furthermore, in obese subjects, the already present endothelial dysfunction will render endothelial inflammation (endotheliitis) due to viral infiltration all the more severe. Added to this is a state of hypercoagulability and a decrease in respiratory capacity, leading to a risk of severe COVID-19 with cardiovascular complications, acute respiratory distress syndrome, and disseminated intravascular coagulation, which can lead to multiple organ failure and even death.

Entities:  

Keywords:  adipocyte; immune cells; inflammasome; insulin resistance; leptin

Year:  2021        PMID: 33668493     DOI: 10.3390/nu13020610

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  6 in total

Review 1.  Reviving the mutual impact of SARS-COV-2 and obesity on patients: From morbidity to mortality.

Authors:  Tapan Behl; Sachin Kumar; Sukhbir Singh; Saurabh Bhatia; Ali Albarrati; Mohammed Albratty; Abdulkarim M Meraya; Asim Najmi; Simona Bungau
Journal:  Biomed Pharmacother       Date:  2022-05-24       Impact factor: 7.419

2.  Active disease-related compound identification based on capsule network.

Authors:  Bin Yang; Wenzheng Bao; Jinglong Wang
Journal:  Brief Bioinform       Date:  2022-01-17       Impact factor: 11.622

3.  Impact of ultra-processed food intake on the risk of COVID-19: a prospective cohort study.

Authors:  Lihui Zhou; Huiping Li; Shunming Zhang; Hongxi Yang; Yue Ma; Yaogang Wang
Journal:  Eur J Nutr       Date:  2022-08-16       Impact factor: 4.865

4.  Cross-National Variations in COVID-19 Mortality: The Role of Diet, Obesity and Depression.

Authors:  Ravi Philip Rajkumar
Journal:  Diseases       Date:  2021-05-06

5.  COVID-19 Outcome Relates With Circulating BDNF, According to Patient Adiposity and Age.

Authors:  Luciele Guerra Minuzzi; Marília Seelaender; Bruna Spolador De Alencar Silva; Eduardo Del Bosco Brunetti Cunha; Marina De Castro Deus; Franciane Thais Falcão Vasconcellos; Luis Felipe Beltrão Marqueze; Ana Carolina Gadotti; Cristina Pellegrino Baena; Telmo Pereira; Karsten Krüger; Andréa Novais Moreno Amaral; Ricardo Aurino Pinho; Fábio Santos Lira
Journal:  Front Nutr       Date:  2021-12-10

6.  Obesity Increases Gene Expression of Markers Associated With Immunosenescence in Obese Middle-Aged Individuals.

Authors:  Diego T Brunelli; Vinicius O Boldrini; Ivan L P Bonfante; Renata G Duft; Keryma Mateus; Leonardo Costa; Mara P T Chacon-Mikahil; Ana M Teixeira; Alessandro S Farias; Cláudia R Cavaglieri
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.